Anisomycin,
Flagecidin,
anisomycin,
Flagecidin,
22862-76-6,
(-)-Anisomycin,
TCMDC-125504,
UNII-6C74YM2NGI,
(2R,3S,4S)-4-hydroxy-2-(4-methoxybenzyl)pyrrolidin-3-yl acetate,
NSC76712,
NSC-76712,
(2R,3S,4S)-2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-acetate,
Upjohn 204t3,
2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-acetate,
6C74YM2NGI,
MLS001066392,
Anisomycin,streptomyces griseolus,
Anisomycin, Streptomyces griseolus,
CHEBI:338412,
1,4,5-Trideoxy-1,4-imino-5-(p-methoxyphenyl)-D-xylo-pentitol 3-acetate,
MFCD00077650,
Antibiotic PA-106,
SMR000471874,
NSC 76712,
[(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl] acetate,
2-p-Methoxyphenylmethyl-3-acetoxy-4-hydroxypyrrolidine,
2-(p-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate,
EINECS 245-269-7,
(2R,3S,4S)-2-((4-Methoxyphenyl)methyl)-3,4-pyrrolidinediol 3-acetate,
(2R,3S,4S)-2-[(4-Methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate,
3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R,3S,4S)-,
3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, (2R,3S,4S)-,
BRN 0020705,
ANM,
AI3-50846,
SR-01000597397,
GNF-Pf-4549,
Wuningmeisu C,
(2R,3S,4S)-2-(p-Methoxyphenylmethyl)-3-acetoxy-4-hydroxypyrrolidine,
3,4-Pyrrolidinediol, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)-,
3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2alpha,3alpha,4beta))-,
6185-RBK-10,
(-) Anisomycin,
3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2-alpha,3-alpha,4-beta))-,
Spectrum_001534,
AC1L5OGT,
Prestwick3_000412,
Spectrum2_000632,
Spectrum4_000748,
Spectrum5_001495,
AC1Q1L8A,
2-[(4-Methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate,
CBiol_002064,
BSPBio_000364,
BSPBio_001436,
KBioGR_001076,
KBioSS_002014,
ZINC954,
5-21-05-00523 (Beilstein Handbook Reference),
DivK1c_000855,
SPECTRUM1503906,
SPBio_000624,
(2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate,
BPBio1_000402,
CHEMBL423192,
cid_253602,
SCHEMBL2270183,
DTXSID5040966,
BDBM63919,
HMS502K17,
KBio1_000855,
KBio2_002014,
KBio2_004582,
KBio2_007150,
BIA4315,
NINDS_000855,
YKJYKKNCCRKFSL-RDBSUJKOSA-N,
ZX-AFC000035,
Bio1_000350,
Bio1_000839,
Bio1_001328,
HMS1922K06,
HMS2096C06,
HMS2231E05,
HMS3267L11,
HMS3678L15,
EBD11190,
BS0234,
CCG-39185,
GA2328,
AKOS015916532,
API0001506,
CS-4981,
DB07374,
SDCCGMLS-0066810.P001,
IDI1_000855,
KS-0000001J,
QTL1_000009,
NCGC00025097-02,
NCGC00025097-03,
NCGC00025097-04,
AS-44380,
HY-18982,
NCI60_041689,
AB00513833,
B6674,
C11281,
Anisomycin, Antibiotic for Culture Media Use Only,
SR-01000597397-1,
SR-01000597397-3,
BRD-K91370081-001-04-6,
BRD-K91370081-001-17-8,
I14-51828,
3, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)-,
Anisomycin from Streptomyces griseolus, >=98% (HPLC), solid,
(2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol 3-Acetate,
(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl acetate,
acetic acid [(2R,3S,4S)-4-hydroxy-2-p-anisyl-pyrrolidin-3-yl] ester,
[(2R,3S,4S)-2-[(4-methoxyphenyl)methyl]-4-oxidanyl-pyrrolidin-3-yl] ethanoate,
3, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, [2S-(2.alpha.,3.alpha.,4.beta.)]-,
3,4-Pyrrolidinediol, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)- (8CI),
acetic acid [(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]-3-pyrrolidinyl] ester,
Anisomycin hydrochloride,
GANT 58,
C14H19NO4,
Anisomycin from Streptomyces griseolus,
NSC 147340,
AR-1L5885,
C14-H19-N-O4,
CID253602,
NSC147340,
A2613,
A-7940,
A11271,
D000841,
Anisomycin, 99%, from Streptomyces griseolus - 10MG 10mg,
[2R-(2alpha,3alpha,4beta)]-2-[(4-methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate,
D-xylo-Pentitol, 1,4,5-trideoxy-1,4-imino-5-(4-methoxyphenyl)-, 3-acetate,
25940-57-2,
3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, [2R-(2.alpha.,3.alpha.,4.beta.)]-,
64048-12-0,